You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cabotegravir

Showing 1 - 25 of 83
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Austin (Cabotegravir Formulation F, Cabotegravir Formulation G)

Not yet recruiting
  • HIV Infections
  • Cabotegravir Formulation F
  • Cabotegravir Formulation G
  • Austin, Texas
    GSK Investigational Site
Sep 4, 2023

HIV Trial (Cabotegravir IR Formulation (reference), Cabotegravir DT Formulation (test 1), Cabotegravir DT Formulation (test 2))

Not yet recruiting
  • HIV Infections
  • Cabotegravir IR Formulation (reference)
  • +2 more
  • (no location specified)
Mar 8, 2023

Implementation and Delivery of Cabotegravir Long Acting

Not yet recruiting
  • HIV Infections
  • Cabotegravir Injection [Apretude]
  • Seattle, Washington
  • +1 more
May 16, 2023

Cisgender Female Patients Who Start on Long Acting Cabotegravir

Not yet recruiting
  • Hiv
  • Cabotegravir Injection [Apretude]
  • Orlando, Florida
  • +2 more
Nov 17, 2023

Satisfaction of HIV-infected Patients Treated With

Not yet recruiting
  • HIV Infections
  • satisfaction survey
  • (no location specified)
Jan 16, 2023

Pre-Exposure Prophylaxis (PrEP), Breast Feeding Trial in Boston, Gaborone (Cabotegravir Injection [Apretude])

Not yet recruiting
  • Pre-Exposure Prophylaxis (PrEP)
  • Breast Feeding
  • Cabotegravir Injection [Apretude]
  • Boston, Massachusetts
  • +1 more
Aug 3, 2023

HIV Trial in Johannesburg (Cabotegravir Injection [Apretude], Tenofovir disoproxil fumarate / emtricitabine (or lamivudine))

Not yet recruiting
  • HIV Infections
  • Cabotegravir Injection [Apretude]
  • Tenofovir disoproxil fumarate / emtricitabine (or lamivudine)
  • Johannesburg, Gauteng, South Africa
    Ezintsha, a division of Wits Health Consortium
Nov 13, 2023

HIV Trial in Las Vegas (Cabotegravir 200 mg/mL, Cabotegravir 400 mg/mL, Recombinant human hyaluronidase PH20 (rHuPH20))

Recruiting
  • HIV Infections
  • Cabotegravir 200 mg/mL
  • +2 more
  • Orlando, Florida
  • +3 more
Dec 1, 2022

HIV Trial in Johannesburg, Kampala, Harare (Oral cabotegravir (CAB), CAB LA, Oral tenofovir disoproxil fumarate/emtricitabine

Active, not recruiting
  • HIV Infections
  • Oral cabotegravir (CAB)
  • +2 more
  • Johannesburg, Gauteng, South Africa
  • +2 more
Dec 13, 2022

Oregon PrEP at Home Study

Not yet recruiting
  • HIV/AIDS
  • Cabotegravir Injection
  • Portland, Oregon
    Oregon Health & Science University
Jul 15, 2023

Long-acting Injectable Cabotegravir + Rilpivirine

Not yet recruiting
  • Patient Satisfaction
  • +3 more
    • Santiago, Region Metropolitana, Chile
      CICUC
    Apr 18, 2023

    HIV Trial in Rio De Janeiro (Cabotegravir Injection)

    Not yet recruiting
    • HIV Infections
    • Cabotegravir Injection
    • Rio De Janeiro, Brazil
      Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ
    Aug 23, 2022

    Healthy Trial in Lenexa, Salt Lake City, Groningen (RPV LA, CAB LA)

    Recruiting
    • Healthy
    • RPV LA
    • CAB LA
    • Lenexa, Kansas
    • +2 more
    Jan 17, 2023

    HIV Trial in Glendale (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir extended release suspension for injection

    Completed
    • HIV Infections
    • Cabotegravir Tablets
    • +3 more
    • Glendale, California
      GSK Investigational Site
    Feb 14, 2022

    HIV-1-infection Trial (Etonogestrel (ENG) Subdermal Implants)

    Not yet recruiting
    • HIV-1-infection
    • Etonogestrel (ENG) Subdermal Implants
    • (no location specified)
    Jul 19, 2022

    HIV Trial (rilpivirine/cabotegravir)

    Not yet recruiting
    • HIV
    • (no location specified)
    Sep 25, 2023

    HIV Trial (DTG/3TC, Cabotegravir (CAB) LA, Rilpivirine (RPV) LA)

    Not yet recruiting
    • HIV Infections
    • (no location specified)
    Jun 13, 2023

    HIV Trial (Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA), Cabotegravir (CAB-LA), Tenofovir

    Not yet recruiting
    • HIV
    • Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC), cabotegravir (CAB-LA)
    • Cabotegravir (CAB-LA), Tenofovir disoproxil fumarate/emtricitabine (TDF-FTC)
    • (no location specified)
    Nov 13, 2023

    HIV Trial in New Zealand, United States (Cabotegravir sodium (Oral Lead In), Cabotegravir 400 mg/mL, Cabotegravir 200 mg/mL)

    Recruiting
    • HIV Infections
    • Cabotegravir sodium (Oral Lead In)
    • +6 more
    • Orlando, Florida
    • +4 more
    Mar 29, 2022

    HIV-1-infection Trial (Cabotegravir/Rilpivirine, Antiretroviral)

    Recruiting
    • HIV-1-infection
    • Kisumu, Kenya
    • +6 more
    Feb 1, 2023

    HIV Trial (CAB LA)

    Not yet recruiting
    • HIV Infections
    • CAB LA
    • (no location specified)
    Nov 21, 2023

    HIV Trial in United States (APRETUDE, Cabotegravir OLI)

    Recruiting
    • HIV Infections
    • Los Angeles, California
    • +16 more
    Oct 24, 2022

    HIV Trial in United States (Cabotegravir (CAB) tablet, CAB LA, Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) tablet)

    Active, not recruiting
    • HIV Infections
    • Cabotegravir (CAB) tablet
    • +2 more
    • Aurora, Colorado
    • +3 more
    Feb 17, 2022

    HIV Trial in Worldwide (Oral Cabotegravir (CAB), Oral Rilpivirine (RPV), Long-Acting Injectable Cabotegravir (CAB LA))

    Recruiting
    • HIV Infections
    • Oral Cabotegravir (CAB)
    • +4 more
    • La Jolla, California
    • +30 more
    Feb 2, 2023

    HIV Trial in Boston (CAB-RPV LA, Standard treatment within an HIV clinic)

    Enrolling by invitation
    • HIV Infections
    • CAB-RPV LA
    • Standard treatment within an HIV clinic
    • Boston, Massachusetts
    • +1 more
    Feb 24, 2022